THL, a premier private equity firm investing in growth companies, recently announced that it has entered into an agreement to acquire a majority interest in IMO Health from Warburg Pincus, a leading global growth investor. IMO Health is a healthcare data enablement company and market leader in clinical terminology solutions.

“THL’s investment in IMO Health validates the next stage of growth for our business, our products, and our employees,” said Ann Barnes, IMO Health’s CEO. “For three decades, IMO Health has been building products critical to addressing healthcare’s most pressing health IT needs, and this partnership allows us to accelerate our expansion in both provider and non-provider markets.”

“We could not be more excited to partner with our new colleagues at IMO Health,” said Joshua Nelson, Managing Director at THL and head of the firm’s healthcare group. “At a time when hospitals and physicians feel the strain of heightened demand and limited capacity, IMO Health’s products help deliver improved patient care and satisfaction. This works to the benefit of those providing care, and those seeking it.”